Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.510
-0.050 (-1.95%)
At close: Mar 6, 2026, 4:00 PM EST
2.550
+0.040 (1.59%)
After-hours: Mar 6, 2026, 7:56 PM EST
Psyence Biomedical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Selling, General & Admin | 3.4 | 3.32 | 1.8 | 1.63 | 1.72 |
| Research & Development | 0.75 | 0.34 | 0.95 | 1.61 | 0.14 |
| Operating Expenses | 4.15 | 3.66 | 2.75 | 3.23 | 1.86 |
| Operating Income | -4.15 | -3.66 | -2.75 | -3.23 | -1.86 |
| Interest Expense | -0.01 | -0.01 | -0.05 | - | - |
| Interest & Investment Income | 0.2 | 0.1 | 0 | 0 | - |
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0 | 0.03 | -0 |
| Other Non Operating Income (Expenses) | -0.04 | 0.51 | 0.57 | - | - |
| EBT Excluding Unusual Items | -4.02 | -3.07 | -2.23 | -3.21 | -1.86 |
| Gain (Loss) on Sale of Investments | 0.45 | 0.02 | - | - | - |
| Other Unusual Items | -0.37 | 4.06 | -48.93 | - | - |
| Pretax Income | -3.94 | 1.01 | -51.16 | -3.21 | -1.86 |
| Net Income | -3.94 | 1.01 | -51.16 | -3.21 | -1.86 |
| Net Income to Common | -3.94 | 1.01 | -51.16 | -3.21 | -1.86 |
| Shares Outstanding (Basic) | 0 | 0 | - | - | - |
| Shares Outstanding (Diluted) | 0 | 0 | - | - | - |
| EPS (Basic) | -34.78 | 32.76 | - | - | - |
| EPS (Diluted) | -34.78 | 32.76 | - | - | - |
| Free Cash Flow | -4.25 | -3.74 | -2.95 | -1.59 | -1.4 |
| Free Cash Flow Per Share | -37.51 | -121.22 | - | - | - |
| EBITDA | -4.15 | -3.66 | -2.75 | - | - |
| D&A For EBITDA | 0.01 | 0 | 0 | - | - |
| EBIT | -4.15 | -3.66 | -2.75 | -3.23 | -1.86 |
Source: S&P Capital IQ. Standard template.
Financial Sources.